Biogipuzkoa
Centro de investigación
Hospital Universitario HM Sanchinarro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario HM Sanchinarro (9)
2024
-
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
eClinicalMedicine, Vol. 71
-
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789
2023
-
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme
European Journal of Cancer, Vol. 182, pp. 3-14
-
“Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain”
Human Immunology, Vol. 84, Núm. 4, pp. 290-295
2021
-
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
Journal of the Neurological Sciences, Vol. 423
2020
-
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)
Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1378-1389
-
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
Helicobacter, Vol. 25, Núm. 3
-
Hospital Mortality and Effect of Adjusting PaO2/FiO2 According to Altitude Above the Sea Level in Acclimatized Patients Undergoing Invasive Mechanical Ventilation. A Multicenter Study
Archivos de Bronconeumologia, Vol. 56, Núm. 4, pp. 218-224
-
Metastatic versus osteoporotic vertebral fractures on MRI: A blinded, multicenter, and multispecialty observer agreement evaluation
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 18, Núm. 3, pp. 267-273